• 1
    Adelmann M, Wood J, Benzel I, Fiori P, Lassmann H, Matthieu JM et al (1995) The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol 63:1727.
  • 2
    Apiwattanakul M, Popescu BF, Matiello M, Weinshenker BG, Lucchinetti CF, Lennon VA et al (2010) Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol 68:757761.
  • 3
    Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C et al (2009) Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 66:617629.
  • 4
    Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C et al (2011) Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479:538541.
  • 5
    Berger T, Weerth S, Kojima K, Linington C, Wekerle H, Lassmann H (1997) Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest 76:355364.
  • 6
    Bettelli E, Baeten D, Jager A, Sobel RA, Kuchroo VK (2006) Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J Clin Invest 116:23932402.
  • 7
    Boxio R, Bossenmeyer-Pourie C, Steinckwich N, Dournon C, Nusse O (2004) Mouse bone marrow contains large numbers of functionally competent neutrophils. J Leukoc Biol 75:604611.
  • 8
    Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M et al (2009) Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 66:630643.
  • 9
    Canard B, Cole ST (1989) Genome organization of the anaerobic pathogen Clostridium perfringens. Proc Natl Acad Sci U S A 86:66766680.
  • 10
    Deguchi S, Deguchi K, Sato K, Yunoki T, Omote Y, Morimoto N et al (2012) HyperCKemia related to the initial and recurrent attacks of neuromyelitis optica. Intern Med 51:26172620.
  • 11
    Devic E (1894) Myélite subaigue compliquée de névrite optique. Bull Méd 8:10331034.
  • 12
    Di Filippo M, Franciotta D, Massa R, Di Gregorio M, Zardini E, Gastaldi M et al (2012) Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica. Neurology 79:11821184.
  • 13
    Gao J, Tan M, Gu M, Marshall C, Ding J, Hu G, Xiao M (2012) Cellular localization of aquaporin-1 in the human and mouse trigeminal systems. PLoS ONE 7:e46379.
  • 14
    Graber DJ, Levy M, Kerr D, Wade WF (2008) Neuromyelitis optica pathogenesis and aquaporin 4. J Neuroinflammation 5:22.
  • 15
    Hehemann JH, Correc G, Barbeyron T, Helbert W, Czjzek M, Michel G (2010) Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature 464:908912.
  • 16
    Ishizu T, Osoegawa M, Mei FJ, Kikuchi H, Tanaka M, Takakura Y et al (2005) Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 128 (Pt 5):9881002.
  • 17
    Jacob A, Saadoun S, Kitley J, Leite M, Palace J, Schon F, Papadopoulos MC (2012) Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence. Mult Scler 18:18011803.
  • 18
    Jarius S, Paul F, Franciotta D, de Seze J, Munch C, Salvetti M et al (2012) Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. Mult Scler 18:11351143.
  • 19
    Jarius S, Wildemann B (2013) The history of neuromyelitis optica. J Neuroinflammation 10:8.
  • 20
    Kalluri SR, Rothhammer V, Staszewski O, Srivastava R, Petermann F, Prinz M et al (2011) Functional characterization of aquaporin-4 specific T cells: towards a model for neuromyelitis optica. PLoS ONE 6:e16083.
  • 21
    Kezuka T, Usui Y, Yamakawa N, Matsunaga Y, Matsuda R, Masuda M et al (2012) Relationship between NMO-antibody and anti-MOG antibody in optic neuritis. J Neuroophthalmol 32:107110.
  • 22
    King LS, Kozono D, Agre P (2004) From structure to disease: the evolving tale of aquaporin biology. Nat Rev Mol Cell Biol 5:687698.
  • 23
    Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T et al (2009) Neuromyelitis optica: passive transfer to rats by human immunoglobulin. Biochem Biophys Res Commun 386:623627.
  • 24
    Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T et al (2010) Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells. Biochem Biophys Res Commun 394:205210.
  • 25
    Kira J, Yamasaki K, Horiuchi I, Ohyagi Y, Taniwaki T, Kawano Y (1999) Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan. J Neurol Sci 166:5357.
  • 26
    Kitic M, Hochmeister S, Wimmer I, Bauer J, Misu T, Mader S et al (2013) Intrastriatal injection of interleukin 1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats. Acta Neuropathol Commun 1:5.
  • 27
    Kitley J, Leite MI, Nakashima I, Waters P, McNeillis B, Brown R et al (2012) Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain 135 (Pt 6):18341849.
  • 28
    Kitley J, Woodhall M, Waters P, Leite MI, Devenney E, Craig J et al (2012) Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 79:12731277.
  • 29
    Kratz APM, Basner RC, Einstein AJ (2012) Appendix: laboratory values of clinical importance. In: Harrison's Online Featuring the Complete Contents of Harrison's Principles of Internal Medicine. DLFA Longo , DL Kasper , SL Hauser , JL Jameson , J Loscalzo (eds), Chapter 60. The McGraw-Hill Companies: New York. Available at: (accessed 19 November 2013).
  • 30
    Krishnamoorthy G, Lassmann H, Wekerle H, Holz A (2006) Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. J Clin Invest 116:23852392.
  • 31
    Lassmann H, Brunner C, Bradl M, Linington C (1988) Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol (Berl) 75:566576.
  • 32
    Leite MI, Coutinho E, Lana-Peixoto M, Apostolos S, Waters P, Sato D et al (2012) Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology 78:16011607.
  • 33
    Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473477.
  • 34
    Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:21062112.
  • 35
    Linington C, Bradl M, Lassmann H, Brunner C, Vass K (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130:443454.
  • 36
    Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM et al (2002) A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125 (Pt 7):14501461.
  • 37
    Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K et al (2011) Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation 8:184.
  • 38
    Madsen LS, Andersson EC, Jansson L, krogsgaard M, Andersen CB, Engberg J et al (1999) A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat Genet 23:343347.
  • 39
    Misu T, Hoeftberger R, Fujihara K, Wimmer I, Takai Y, Nishiyama S et al (2013) Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica. Acta Neuropathol 125:815827.
  • 40
    Nelson PA, Khodadoust M, Prodhomme T, Spencer C, Patarroyo JC, Varrin-Doyer M et al (2010) Immunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica. PLoS ONE 5:e15050.
  • 41
    Nishiyama S, Ito T, Misu T, Takahashi T, Kikuchi A, Suzuki N et al (2009) A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset. Neurology 72:19601961.
  • 42
    Oberheim NA, Wang X, Goldman S, Nedergaard M (2006) Astrocytic complexity distinguishes the human brain. Trends Neurosci 29:547553.
  • 43
    Papazisi L, Gorton TS, Kutish G, Markham PF, Browning GF, Nguyen DK et al (2003) The complete genome sequence of the avian pathogen Mycoplasma gallisepticum strain R(low). Microbiology 149 (Pt 9):23072316.
  • 44
    Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM et al (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65:7883.
  • 45
    Pohl M, Fischer MT, Mader S, Schanda K, Kitic M, Sharma R et al (2011) Pathogenic T cell responses against aquaporin 4. Acta Neuropathol (Berl) 122:2134.
  • 46
    Popescu BF, Lennon VA, Parisi JE, Howe CL, Weigand SD, Cabrera-Gomez JA et al (2011) Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology 76:12291237.
  • 47
    Ratelade J, Bennett JL, Verkman AS (2011) Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postrema. PLoS ONE 6:e27412.
  • 48
    Rostasy K, Mader S, Hennes E, Schanda K, Gredler V, Guenther A et al (2012) Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Mult Scler 19:10521059.
  • 49
    Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC (2010) Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 133 (Pt 2):349361.
  • 50
    Saadoun S, Waters P, Macdonald C, Bridges LR, Bell BA, Vincent A et al (2011) T cell deficiency does not reduce lesions in mice produced by intracerebral injection of NMO-IgG and complement. J Neuroimmunol 235:2732.
  • 51
    Saadoun S, Waters P, MacDonald C, Bell BA, Vincent A, Verkman AS, Papadopoulos MC (2012) Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain. Ann Neurol 71:323333.
  • 52
    Sandhu A, Harford A, Singh P, Alas E (2012) Is thymoglobulin or rituximab the cause of this serum sickness? A case report of serum sickness dilemma and literature review. Case Rep Med 2012:234515.
  • 53
    Sellner J, Hemmer B, Muhlau M (2010) The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes. J Autoimmun 34:371379.
  • 54
    Storch MK, Stefferl A, Brehm U, Weissert R, Wallstrom E, Kerschensteiner M et al (1998) Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 8:681694.
  • 55
    Suzuki N, Takahashi T, Aoki M, Misu T, Konohana S, Okumura T et al (2010) Neuromyelitis optica preceded by hyperCKemia episode. Neurology 74:15431545.
  • 56
    Terris J, Ecelbarger CA, Marples D, Knepper MA, Nielsen S (1995) Distribution of aquaporin-4 water channel expression within rat kidney. Am J Physiol 269 (Pt 2):F775F785.
  • 57
    Tradtrantip L, Zhang H, Anderson MO, Saadoun S, Phuan PW, Papadopoulos MC et al (2012) Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica. FASEB J 26:21972208.
  • 58
    Tradtrantip L, Zhang H, Saadoun S, Phuan PW, Lam C, Papadopoulos MC et al (2011) Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica. Ann Neurol 71:314322.
  • 59
    Varrin-Doyer M, Spencer CM, Schulze-Topphoff U, Nelson PA, Stroud RM, Cree BA, Zamvil SS (2012) Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter. Ann Neurol 72:5364.
  • 60
    Wang H, Dai Y, Qiu W, Zhong X, Wu A, Wang Y et al (2011) HLA-DPB1 0501 is associated with susceptibility to anti-aquaporin-4 antibodies positive neuromyelitis optica in southern Han Chinese. J Neuroimmunol 233:181184.
  • 61
    Warabi Y, Matsumoto Y, Hayashi H (2007) Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination. J Neurol Sci 252:5761.
  • 62
    Wauben MH, van der Kraan M, Grosfeld-Stulemeyer MC, Joosten I (1997) Definition of an extended MHC class II-peptide binding motif for the autoimmune disease-associated Lewis rat RT1.BL molecule. Int Immunol 9:281290.
  • 63
    Willison HJ, Linington C (2012) Antibodies to MOG in NMO: a seasoned veteran finds a new role. Neurology 79:11981199.
  • 64
    Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6:805815.
  • 65
    Wingerchuk DM, Weinshenker BG (2012) The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Mult Scler 18:510.
  • 66
    Wucherpfennig KW, Strominger JL (1995) Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695705.
  • 67
    Yamamoto K, Matsunaga S, Matsui M, Takeda N, Yamatodani A (2002) Pica in mice as a new model for the study of emesis. Methods Find Exp Clin Pharmacol 24:135138.
  • 68
    Yamasaki K, Horiuchi I, Minohara M, Kawano Y, Ohyagi Y, Yamada T et al (1999) HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain 122 (Pt 9):16891696.
  • 69
    Yokoyama N, Niino M, Takahashi T, Matsushima M, Maruo Y (2012) Seroconversion of neuromyelitis optica spectrum disorder with hyperCKemia: a case report. Eur J Neurol 19:e143.
  • 70
    Rat phenome database of the National BioResource Project for the Rat in Japan. Avalable at: (accessed 19 November 2013).
  • 71
    Mouse phenome database. The Jackson Laboratory, Bar Harbor, ME. Available at: (accessed 18 November 2013).